Frequency and characteristics of docetaxel-induced radiation recall phenomenon

Conclusions: The incidence of RRP induced by docetaxel was 1.8%, making it a comparatively rare condition. However, docetaxel is increasingly being used for patients with head and neck tumors, and caution regarding development of RRP is warranted after use of docetaxel after high-dose radiotherapy with photon beams of ≤6 MV.